Clinical Trial 52812

Waterbury, CT 06708


We are seeking participants for a Type 2 Diabetic clinical research study to demonstrate whether switching from a stable dose of a Glucagon-like peptide-1 receptor agonists (GLP-1 RA) (Victoza, Saxenda, Trulicity, Ozempic) to Tirzepatide 5 mg once weekly will help lower HbA1c.

  • 18 years of age or older
  • Have a diagnosis of type 2 diabetes
  • Have an HbA1c value of ≥6.5% (≥48 mmol/mol) to ≤9.0%
  • Body Mass Index (BMI) ≤ 25 kg/m²
  • Additional qualification criteria exist

Qualified Participants May Receive:

  • Reimbursement available for time and travel
  • You are provided study-related care and study medicine at no cost (no health insurance required)
  • You may help make a difference for yourself and for people like you

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.